A positive urine test confirms Legionnaires’ disease in minutes, which is exactly why so many work-ups stop there. The urinary antigen test is fast, cheap and rightly the first move in suspected cases, and quietly blind to whole categories of Legionella that only other methods catch.
If you already know the urine test exists, the question worth your time is not “does it work” but “what does a single negative, or even a single positive, actually leave unanswered”. That is where culture, PCR and serology earn their place, and where the difference between confirming a case and tracing it back to a building lives.
What the urinary antigen test does, and where it stops
The urinary antigen test (UAT) detects a soluble Legionella antigen excreted in urine. It is quick, needs only a urine sample rather than a productive cough, and stays usable even after antibiotics have started, all reasons it dominates frontline testing [1].
Its limits follow from what it detects. The widely used assays are built around Legionella pneumophila serogroup 1, which accounts for the large majority of reported community cases but not all of them [1][2]. A patient with disease caused by another serogroup, or by a non-pneumophila species, can be genuinely infected and UAT-negative. The test answers “is this L. pneumophila serogroup 1” far better than it answers “is this Legionella”.
Two further quirks matter clinically. Sensitivity is generally reported as higher in more severe disease, so milder cases are easier to miss. And the antigen can persist in urine for an extended period after the acute illness, commonly described as weeks, sometimes longer [3][5]. A positive result therefore confirms infection but does not date it, which complicates a patient who was unwell, recovered, and is now being investigated for something else.
So the UAT is the right opening test and a poor closing one. A negative does not exclude Legionnaires’ disease, and a positive does not, on its own, give you an organism to work with.
Lower respiratory tract culture: the slow test that does the most
Culture of a lower respiratory sample, sputum, induced sputum, endotracheal aspirate or bronchoalveolar lavage, is treated as the reference method [2]. It is the test that recovers the actual organism rather than a marker of it.
That isolate is the prize. Culture is not restricted to one serogroup or species, so it can confirm cases the UAT never would. It supports antimicrobial susceptibility work where needed. And, decisively for anyone responsible for a building, it is the only routine route to a clinical isolate that can be compared against environmental samples by sequence-based typing, the molecular fingerprinting that links a person’s infection to a specific water source [2][3]. Without a clinical isolate, an investigation can suspect a building but struggle to prove the match.
The trade-offs are real. Legionella needs selective media and is slow to grow, so results take days, not hours. A good lower respiratory specimen is harder to obtain than a urine pot, especially from a patient with a dry cough. Sensitivity depends heavily on sample quality, laboratory technique and whether antibiotics were already running. Reported yields vary widely, which is the honest answer to “how often does culture work”. None of that diminishes its value; it just explains why culture is requested alongside, not instead of, faster tests.
The diagnostic pathway, drawn out
Picture the work-up as a flow from two sample types into four outputs.
On the left, two specimen sources feed the system. A urine sample flows into the UAT. A lower respiratory sample, sputum, aspirate or lavage, branches into two laboratory paths at once: culture and nucleic acid amplification (PCR). Running alongside the whole picture, drawn from blood rather than the chest, sits paired serology: an acute serum taken early and a convalescent serum taken later.
Now the outputs, reading by speed. Fastest is the UAT result, a same-visit yes/no for L. pneumophila serogroup 1. Next, PCR, typically returning within roughly a day, flags Legionella nucleic acid across a broader range of species depending on the assay, but hands back no living organism. Slower, over several days, culture returns the isolate, the box from which an arrow runs onward to sequence-based typing, and from there to the environmental isolates collected during any source investigation. Last and retrospective, serology confirms via a significant rise between the paired sera, useful mainly after the fact.
The shape of the diagram is the lesson: the quickest box answers a narrow question, and the box that feeds source tracing is the slowest one. Lean only on the fast path and the arrow to the water system never gets drawn [2][3].
PCR and serology: the supporting roles
PCR (nucleic acid amplification) on respiratory samples has grown into a strong complement to the UAT. It is fast, can be more sensitive than culture in some settings, and, assay depending, can pick up species and serogroups the urine test misses [1][2]. Its limitation is the flip side of culture’s strength: it detects genetic material, not a viable isolate, so it does not by itself give you the organism for typing. Treat a PCR-positive case as a strong prompt to still attempt culture where feasible.
Paired serology compares antibody levels in an early sample and a later one, looking for a meaningful rise across the illness [1]. Because the convalescent sample is taken well after presentation, it rarely changes immediate management and is mostly a confirmatory or epidemiological tool. A single antibody titre is hard to interpret. It rounds out a diagnosis rather than driving the first decisions.
Used together, the toolkit covers each method’s blind spot: the UAT for speed, PCR for breadth and speed, culture for the isolate, serology for retrospective confirmation [1][2].
Why this matters past the bedside
For the clinical team, the practical message is restraint about negatives: if the picture fits Legionnaires’ disease, a negative UAT should not close the door, and a lower respiratory sample for culture and PCR is worth pursuing, particularly in severe or non-responding pneumonia. Choice of test and treatment remains a clinical decision under current NHS and specialist guidance [4].
For infection-prevention, occupational health and building duty holders, the takeaway is narrower but sharp: ask whether a clinical isolate was obtained. A confirmed case with a typed isolate gives a source investigation something to match against; a urine-positive-only case may never be linkable to your water system even if it came from there [2][3]. That single question shapes how confidently any building can be implicated or cleared.
This article is general educational background, not clinical guidance, and nothing here is a substitute for assessment by the treating clinician, who owns diagnosis and prescribing under current NHS and specialist guidance [4]. Equally, deciding what a confirmed case means for a particular water system, whether sampling, review or remediation is warranted, is a judgement for a competent, suitably qualified risk assessor working from your site’s own circumstances, not something to read off a test result.
FAQ
If the urinary antigen test is negative, is Legionnaires’ disease ruled out?
No. A negative urinary antigen test does not exclude the disease. The common assays are oriented to L. pneumophila serogroup 1, so other serogroups and non-pneumophila species can produce a true infection with a negative urine result, and sensitivity tends to be lower in milder disease [1][2]. If the clinical picture still fits, further testing on a lower respiratory sample is the logical next step, at the treating clinician’s discretion.
Why request culture if the urine test is already positive?
Because the urine test confirms infection but gives you no organism. Culture recovers an isolate that can be characterised and, critically, compared with environmental samples by sequence-based typing during a source investigation [2][3]. A positive urine result alone often cannot be tied to a specific building, so where Legionnaires’ disease is confirmed, attempting culture keeps the option of source tracing open.
Which species does the standard urine test miss?
It is built chiefly around L. pneumophila serogroup 1 [1]. Infections from other L. pneumophila serogroups and from non-pneumophila species, the kind more often seen in immunocompromised patients, may not be detected by the urinary antigen test, and are more reliably found by culture or a suitably broad PCR assay [1][2].
As a duty holder told a case is linked to my site, what should I ask?
Ask, through the public health team leading the investigation, whether a clinical isolate was obtained and typed. The strength of any link between a person’s illness and a water system usually rests on matching a clinical isolate to an environmental one [2][3]. That answer frames how firmly your building can be implicated, and it sits alongside, not instead of, a competent risk assessor’s review of your system.
Sources
- Centers for Disease Control and Prevention, “Legionella (Legionnaires’ Disease and Pontiac Fever): Clinical Testing and Diagnosis”. https://www.cdc.gov/legionella/php/laboratories/index.html
- UK Health Security Agency, “Legionnaires’ disease: guidance, data and analysis”. https://www.gov.uk/government/collections/legionnaires-disease-guidance-data-and-analysis
- European Centre for Disease Prevention and Control, “Legionnaires’ disease”. https://www.ecdc.europa.eu/en/legionnaires-disease
- NHS, “Legionnaires’ disease”. https://www.nhs.uk/conditions/legionnaires-disease/
- World Health Organization, “Legionellosis fact sheet”. https://www.who.int/news-room/fact-sheets/detail/legionellosis